Home / Inspections / 806356

FDA Inspection 806356 — ARL Biopharma, Inc.

ARL Biopharma, Inc. — FEI 3003644883

The FDA completed an inspection of ARL Biopharma, Inc. on November 8, 2012 in Oklahoma City, OK. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 8, 2012
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Oklahoma City, OK (United States)

Facility

Other inspections at this facility

  • 1322550 (NAI Fri May 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1102393 (VAI Fri Sep 20 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 965921 (NAI Fri Mar 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 701726 (NAI Fri Nov 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 651237 (NAI Thu Feb 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources